Prevailing insights into anastomotic angles of surgically created arteriovenous fistulas: a literature review

关于外科手术创建的动静脉瘘吻合角度的现有见解:文献综述

阅读:3

Abstract

OBJECTIVE: An arteriovenous fistula (AVF) is the most common type of vascular access, given its low infection rate, few complications, good patency potential, and long service life. Although preferred for most patients with chronic kidney disease (CKD), those undergoing dialysis continue to experience AVF surgical failures and complications, with 60% of AVFs failing to mature. The anastomotic angles chosen for AVF creation are usually ones that surgeons find easiest to manually control. At present, many sources have confirmed that variations in anastomotic angle culminate in differing geometric parameters of perianastomotic blood vessels, thus affecting the AVF maturation process. METHODS: This publication was intended to highlight the progress achieved with respect to AVF anastomotic angle conventions through collective outcomes of clinical analyses, basic research, computational fluid dynamics (CFD) studies, and VasQ external stent trials. The insights gained may well fuel clinical efforts to implement more durable blood channels in patients with end-stage kidney disease (ESKD). For our purposes, we described anastomotic angles as acute (< 30°), intermediate (30-70°), or obtuse (> 70°), rather than invoking mathematical standards. RESULTS: In clinical research, two studies support the acute angle, three studies support the intermediate angle, three studies support the obtuse angle. In CFD research, one article supports the acute angle, six articles support the intermediate angle, and one article supports obtuse angles. CONCLUSIONS: Our analysis demonstrates an intermediate angle of 30-70° would be an optimal angle for AVF anastomosis, according to the existing research results. VasQ external stent devices have yielded superior AVF maturity and patency by maintaining anastomosed arteries and veins at angles of 40-50°, resulting in improved patient outcomes clinically, which supports the use of the device in the clinical practice. CLINICAL TRIAL NUMBER: Not applicable.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。